|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
CSC Pharmaceutical (ЦСЦ Фармасютикъл)
Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name CSC Pharmaceutical Ltd. Bulgaria (ЦСЦ Фармасютикъл Лтд-България ЕООД) Headquarters 10, Asen Iordanov Blvd.; Sofia; Sofia - city; 1592 |
Status: Non-Listed Legal Form: Limited Liability Company Operational Status: Operational BG VAT Identification Code: BG831902889 BULSTAT: 831902889 Financial Auditors: Ernst & Young (2011) Incorporation Date: November 3, 1992 Total Employees: 59 Tel: (+359 2) 975 13 95, 975 13 96 |
|
Company Description |
| CSC Pharmaceutical Bulgaria, which was established in 2000, is primarily engaged in wholesaling pharmaceuticals. The company is part of Italian Angelini S.p.A. It distributes products of major manufacturers from Switzerland, Italy, France, Spain, the USA. |
Company Analysis |
| According to the Individual - Audited financial statement for the Year of 2010, total net operating revenues decreased with -19.21%, from BGN 17,634 thousands to BGN 14,246 thousands. Operating result decreased from BGN 2,258 thousands to BGN 43 thousands which means -98.10% change. The results of the period decreased -99.22% reaching BGN 16 thousands at the end of the period against BGN 2,048 thousands last year. Return on equity (Net income/Total equity) went from 97.52% to 0.76%, the Return On Asset (Net income / Total Asset) went from 20.19% to 0.15% and the Net Profit Margin (Net Income/Net Sales) went from 11.61% to 0.11% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 400.66% compared to 381.86% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 1.18 to 1.16 when compared to the previous year. |
Key Executives |
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2010 Y (non-cons) |
2009 Y (non-cons) |
|
 | ||
| Audited | Audited | |
| ||
| ISI Financial Statements | ISI Financial Statements | |
| ||
| Unit | Thousands | Thousands |
| ||
Balance Sheet
| ||
Total Assets |
10,630 |
10,144 |
| ||
Current Assets |
X,XXX |
X,XXX |
| ||
Total Liabilities |
X,XXX |
X,XXX |
| ||
Shareholders Equity |
X,XXX |
X,XXX |
| ||
Current Liabilities |
X,XXX |
X,XXX |
| ||
| * All the accounts are in BGN. | ||
Income Statement
| ||
Total Operating Revenue |
XX,XXX |
XX,XXX |
| ||
Operational Profit (Loss) |
XX |
X,XXX |
| ||
Net Profit (Loss) |
XX |
X,XXX |
| ||
| * All the accounts are in BGN. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
X.XX% |
XX.XX% |
| ||
Annualised Return on Assets (ROA) |
X.XX% |
XX.XX% |
| ||
Return on Equity (ROE) |
X.XX% |
XX.XX% |
| ||
Annualised Return on Equity (ROE) |
X.XX% |
XX.XX% |
| ||
Return on Sales (ROS) |
X.XX% |
XX.XX% |
| ||
Return on Capital |
X.XX% |
XX.XX% |
| ||
Operating Profit Margin |
X.X% |
XX.XX% |
| Efficiency Ratios | ||
| ||
Accounts Receivable Turnover |
XX.XXx |
X.XXx |
| ||
Current asset turnover |
X.XXx |
X.XXx |
| ||
Fixed-asset turnover |
XX.XXx |
XX.XXx |
| ||
Asset Turnover |
X.XXx |
X.XXx |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
XX |
X,XXX |
| ||
EBITDA |
XXX |
X,XXX |
| ||
Bookvalue (BV) |
X,XXX |
X,XXX |
| ||
Net Cash |
-X,XXX |
-X,XXX |
| Liquidity Ratios | ||
| ||
Current Ratio |
XXX.XX% |
XXX.XX% |
| ||
Quick ratio |
XX.XX% |
XX.XX% |
| ||
Doom's day ratio |
XX.X% |
XX.XX% |
| Leverage Ratios | ||
| ||
Leverage ratio |
XXX.XX% |
XXX.XX% |
| ||
Debt to equity |
XXX.XX% |
XXX.XX% |
| ||
Debt to total assets |
XX.XX% |
XX.X% |
| ||
Long Term Debt to Capital |
X.XX% |
X.XX% |
| Trend Ratios | ||
| ||
Revenue Trend |
XX.XX% |
XXX.XX% |
| ||
Net Income Trend |
X.XX% |
-XXX.XX% |
| ||
Operating Income Trend |
X.X% |
-XXX.X% |
| ||
 |